https://www.avient.com/investor-center/news/polyone-names-dr-david-jarus-vice-president-research-and-development
Comptek, SilCoTec, Gordon Composites and Polystrand, including whether such businesses will be accretive, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; our ability to continue to pay cash dividends, including at the increasing rate, which will be subject to, among other factors, market conditions, our cash flow and cash requirements and restrictions contained in any of our debt agreements; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/polyone-announces-increase-quarterly-dividend
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to realize anticipated savings and operational benefits from the realignment of assets, including the closure of manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of service or quality caused by such closings and/or production shifts; separation and severance amounts that differ from original estimates; amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, such as Gordon Composites and Polystrand, including whether such businesses will be accretive, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
Most notably, our composites business is benefitting from increased demand for outdoor high performance applications.
continued.
Net income from continuing operations attributable to
https://www.avient.com/sites/default/files/resources/TPE_Overmolding_Solutions_for_Engineering_Thermoplastics.pdf
TPE Overmolding Solutions for Engineering Thermoplastics
Rajesh Varma, Applications Development Manager
Dan Liu, Materials Scientist
Walter Ripple, Director of Marketing
Krishna Venkataswamy, Director of Research and Development
Abstract
Demands continue to increase in various consumer applications for
ergonomically designed products.
To enhance the performance in the end use
application and marketability of such consumer products the use of a
thermoplastic elastomers as an overmold, onto the engineering plastic has
continued to grow.
However, most of the combinations
were limited to hard thermoplastics only.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
Examples include:
• Barrier technologies that preserve the shelf-life
and quality of food, beverages, medicine and
other perishable goods through high-
performance materials that require less plastic
• Light-weighting solutions that replace heavier
traditional materials like metal, glass and wood,
which can improve fuel efficiency in all modes of
transportation
• Breakthrough technologies that minimize
wastewater, improve the recyclability of materials
and advance a circular economy
• Composite solutions to support accelerated
growth of 5G / fiber-optic infrastructure
investment as the world demands greater and
faster connectivity
Avient employs approximately 8,400 associates and is
certified ACC Responsible Care® and a founding
member of the Alliance to End Plastic Waste.
Operational Excellence
Empowers us to respond to the voice of the customer with relentless continuous
improvement.
We also monitor earnings (defined as net income from continuing operations) before interest,
taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a
supplement to our GAAP measures.
https://www.avient.com/industries/packaging/household-packaging/fabric-care
Thermoplastic Elastomers
Continuous Glucose Monitors (CGM)
Advanced Mobility Composite Structures
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
GUIDANCE
DEBT / LEVERAGE R EDUCTION
• Completed sale of Distribution
and paid down $750M of debt
in November
• Strong free cash flow in fourth
quarter reduced leverage and
enabled paydown of additional
$200M of debt
• Fixed/Floating Debt Ratio 63/37
• Proven track record of
deleveraging following
acquisitions through consistent
free cash flow generation
$725 $725 $725
$575 $500 $400
$600
$525
$425
$650
$650
$650
$600
$2.40B
$2.20B
2030 Notes
2029 Term Loan
2026 Term Loan
2025 Notes
After Distribution
Divestiture
Year-End
4
Year-End
Leverage
3.8x 3.1x 2.9x
2023 Notes
After Avient
Protective Materials
Acquisition
$3.15B
20 22 TRA NSF OR MATI ONAL PORTFOLI O
ENHA NC EMENTS
5
EBITDA margins expanded
from 12% to 16%
Diversified end markets
with reduced exposure to
more cyclical industries
Dyneema®
Acquisition
$1.48B acquisition
strengthens composites
platform
Significantly improved
EBITDA margins $950M divestiture results
in 100% specialty sales
Strong exit multiple of 10x
TTM EBITDA despite
market volatility
Distribution
Divestiture
Improved
Portfolio
G ROW I NG C OM PO SI T ES P LAT F OR M
C O NT R I BU TI O NS TO S EM S EG ME NT
6
Note: 2022 is pro forma for Avient Protective Materials
2016 Sales 2022 Sales
Advanced
Composites
51%
$560M $1,300M
Advanced
Composites
9%
C O M P O S I T E S P O R T F O L I O
D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y
LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers
7
ADVA NC ED C OM POSI TES PERFORMA NCE
8 (1) Pro forma for the acquisition of Avient Protective Materials
Sales
$51
$84
$212
$668
2016 2018 2020 2022
$4
$10
$41
$169
2016 2018 2020 2022
EBITDA
(1) (1)
($ in millions)
PORTFOLIO EVOLUTION AND EPS EXPANSION
9
Adj.
We also monitor earnings (defined as net income from continuing operations) before interest,
taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a
supplement to our GAAP measures.
Reconciliation of Pro Forma Net Debt December 31, 2022
Short-term and current portion of long term debt $ 2.2
Total long-term debt, net 2,176.7
Unamortized discount and debt issuance cost 37.4
Total debt $ 2,216.3
Cash (641.1)
Net taxes due from sale of business 105.0
Adjusted cash $ (536.1)
Net debt $ 1,680.2
Year Ended
December 31,
Reconciliation to EBITDA and Adjusted EBITDA 2006 2018
Sales $ 2,622.4 $ 3,533.4
Net income from continuing operations – GAAP $ 133.5 $ 160.8
Income tax expense 29.7 36.4
Interest expense 63.1 62.8
Depreciation and amortization 57.1 91.5
EBITDA $ 283.4 $ 351.5
Special items, before income tax (34.0) 59.5
Depreciation and amortization included in special items — (3.0)
JV - equity income (107.0) —
Adjusted EBITDA $ 142.4 $ 408.0
EBITDA as a % of sales 5.4 % 11.5 %
2
Reconciliation of Adjusted EPS 2006 2018
Net income from continuing operations attributable to Avient common shareholders $ 130.9 $ 161.1
Joint venture equity earnings, after tax (68.5) —
Special items, after tax (21.2) 44.6
Special items, tax adjustments (30.0) (10.4)
Amortization expense, after tax 1.4 19.5
Adjusted net income from continuing operations attributable to Avient common
shareholders $ 12.6 $ 214.8
Diluted shares 92.8 80.4
Adjusted EPS attributable to Avient common shareholders $ 0.14 $ 2.67
Three Months
Ended Year Ended Year Ended
Reconciliation of Pro Forma Adjusted Earnings per Share December 31, 2022 December 31, 2021
Net (loss) income from continuing operations attributable to Avient
shareholders $ (17.0) $ 82.8 $ 151.8
Special items, after tax 38.3 116.2 50.0
Amortization expense, after-tax 14.6 49.0 44.9
Adjusted net income from continuing operations excluding special
items 35.9 248.0 246.7
Pro forma adjustments* 2.5 13.6 9.9
APM pro forma amortization expense, after tax* — 19.1 21.2
Pro forma adjusted net income from continuing operations attributable
to Avient shareholders $ 38.4 $ 280.7 $ 277.8
Weighted average diluted shares 91.7 92.2 92.1
Pro forma adjusted EPS - excluding special items pro forma for APM
acquisition $ 0.42 $ 3.04 $ 3.02
* Pro forma adjustment to reflect APM results for the period before Avient ownership including the impacts of debt financing and paydown of
debt with net proceeds from the Distribution sale.
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=41
Advanced Composites Explained
Thermoplastic Elastomers in Medical Devices - White Paper
Thermoplastic Elastomers for Healthcare - Industry Bulletin
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=44
Advanced Composites Explained
Thermoplastic Elastomers in Medical Devices - White Paper
Thermoplastic Elastomers for Healthcare - Industry Bulletin
https://www.avient.com/idea/polycase-launches-revolutionary-polymer-based-ammunition
The Avient team used their extensive knowledge and experience working with high-density polymers to develop a specialized Gravi-Tech™ high-density polymer composite that met PolyCase’s needs and fit the profile of their proprietary injection molding process.